Scott Jewell


Senior Scientific Investigator and Director of Program for Biospecimen Science, Van Andel Institute

Dr. Jewell is Director for the Program of Core Technologies including the Pathology and Biorepository Core at the Van Andel Research Institute (VARI) and a Professor in the Van Andel Institute Graduate School. Dr. Jewell received his B.S., M.S. and PhD degrees from The Ohio State University in Columbus, Ohio, in Immunology and Experimental Pathology. Dr. Jewell has worked in the field of anatomic pathology, biospecimen science and biobanking for more than 30 years. He has served as President of the International Society for Biological and Environmental Repositories (ISBER), directed several projects in biobanking including the NCI Cooperative Human Tissue Network at Ohio State University, the Cancer and Leukemia Group B (now Alliance) Pathology Coordinating Office, Executive Director of OSU’s Human Tissue Resource Network and the OSU Comprehensive Cancer Center’s Biorepository and Biospecimen Resource. Dr. Jewell has served on several national committees and external advisory boards, including several ISBER committees, the Clinical Cooperative Group Banking Committee, the Biospecimen Subcommittee for NCI, AACR, and FDA’s Critical Path Initiative and currently he serves as a member of the Biorepository Accreditation Program of the College of American Pathologists (CAP). At VARI, Dr. Jewell operates the Comprehensive Biospecimen Resource (CBR) for the NCI’s Cancer Human Biobank (caHUB; http://biospecimens.cancer.gov/programs/cahub/default.asp ) and serves as the biorepository for the Multiple Myeloma Research Foundation’s CoMMpass Study (http://www.themmrf.org/research-partners/the-commpass-study/). Dr. Jewell’s research focuses on biospecimen science to improve the standards and practices for the collection, processing, storage and distribution of biospecimens.

Listen to an interview with Scott



New to Mendelspod?

We advance life science research, connecting people and ideas.
Register here to receive our newsletter.

or skip signup